ArticleAmerican health & drug benefits2016

Pomalyst (Pomalidomide) Received a New Indication for Patients with Relapsed and/or Refractory Multiple Myeloma.

Lisa A RaedlerPubMed ↗Full text ↗

No numbers read from the abstract.